Literature DB >> 7499000

Genotypes and virus load in patients with hepatitis C infection.

H Hofmann1.   

Abstract

Virus load was tested by means of PCR calibrated with standards and HCV genotypes were determined by the LIPA-technique using sera from 123 HCV patients. Of these 39 were on renal hemodialysis treatment, 19 suffered from hemophilia, 13 were i.v. drug users and the remaining 52 had none of these risk factors (chronic hepatitis group). The most prevalent subtype in Austria was 1b followed by 3a and 1a. However, genotype 1b infections were found relatively less often in hemophilia patients and drug users than in the other groups, indicating that hemophiliacs probably had been infected by an antihemophilic plasma coming from South American or Asian donors. The highest amounts of virus were found in patients infected with genotype 3a. Determination of the patient's virus load and of the infecting subtype of HCV may be helpful in planning interferon alpha therapy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499000     DOI: 10.1007/bf01793852

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  44 in total

1.  Viral and host factors that contribute to efficacy of interferon-alpha 2a therapy in patients with chronic hepatitis C.

Authors:  A Matsumoto; E Tanaka; T Suzuki; H Ogata; K Kiyosawa
Journal:  Dig Dis Sci       Date:  1994-06       Impact factor: 3.199

2.  Hepatitis C virus genotypes in France: comparison of clinical features of patients infected with HCV type I and type II.

Authors:  D Qu; J S Li; L Vitvitski; S Mechai; F Berby; S P Tong; F Bailly; Q S Wang; J L Martin; C Trépo
Journal:  J Hepatol       Date:  1994-07       Impact factor: 25.083

Review 3.  Genetic variation of the hepatitis C virus (HCV) genome: random events or a clinically relevant issue?

Authors:  C Bréchot; D Kremsdorf
Journal:  J Hepatol       Date:  1993-03       Impact factor: 25.083

4.  Quantification of hepatitis C virus by competitive reverse transcription-polymerase chain reaction: increase of the virus in advanced liver disease.

Authors:  N Kato; O Yokosuka; K Hosoda; Y Ito; M Ohto; M Omata
Journal:  Hepatology       Date:  1993-07       Impact factor: 17.425

5.  Factors useful in predicting the response to interferon therapy in chronic hepatitis C.

Authors:  A Tsubota; K Chayama; Y Arase; I Koida; S Saitoh; K Ikeda; S Iwasaki; T Matsumoto; M Kobayashi; H Kumada
Journal:  J Gastroenterol Hepatol       Date:  1993 Nov-Dec       Impact factor: 4.029

6.  Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus.

Authors:  K Yoshioka; S Kakumu; T Wakita; T Ishikawa; Y Itoh; M Takayanagi; Y Higashi; M Shibata; T Morishima
Journal:  Hepatology       Date:  1992-08       Impact factor: 17.425

7.  Quantitation of hepatitis C virus RNA by competitive polymerase chain reaction.

Authors:  S Kaneko; S Murakami; M Unoura; K Kobayashi
Journal:  J Med Virol       Date:  1992-08       Impact factor: 2.327

8.  Hepatitis C virus genotypes are not responsible for development of serious liver disease.

Authors:  M Yamada; S Kakumu; K Yoshioka; Y Higashi; K Tanaka; T Ishikawa; M Takayanagi
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

9.  Entire nucleotide sequence and characterization of a hepatitis C virus of genotype V/3a.

Authors:  M Sakamoto; Y Akahane; F Tsuda; T Tanaka; D G Woodfield; H Okamoto
Journal:  J Gen Virol       Date:  1994-07       Impact factor: 3.891

10.  Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity.

Authors:  P Simmonds; F McOmish; P L Yap; S W Chan; C K Lin; G Dusheiko; A A Saeed; E C Holmes
Journal:  J Gen Virol       Date:  1993-04       Impact factor: 3.891

View more
  4 in total

1.  Correlates of high hepatitis C virus RNA load in a cohort of HIV-negative and HIV-positive individuals with haemophilia.

Authors:  S M Gadalla; L R Preiss; M E Eyster; J J Goedert
Journal:  J Viral Hepat       Date:  2011-03       Impact factor: 3.728

2.  Prevalence of hepatitis C virus infection in Hashimoto's thyroiditis.

Authors:  B Wagner; H Vierhapper; H Hofmann
Journal:  BMJ       Date:  1996-03-09

3.  Different hepatitis C virus (HCV) RNA load profiles following seroconversion among injecting drug users without correlation with HCV genotype and serum alanine aminotransferase levels.

Authors:  M Beld; M Penning; M McMorrow; J Gorgels; A van den Hoek; J Goudsmit
Journal:  J Clin Microbiol       Date:  1998-04       Impact factor: 5.948

Review 4.  Molecular and contextual markers of hepatitis C virus and drug abuse.

Authors:  Paul Shapshak; Charurut Somboonwit; Lydia N Drumright; Simon D W Frost; Deborah Commins; Timothy L Tellinghuisen; William K Scott; Robert Duncan; Clyde McCoy; J Bryan Page; Brian Giunta; Francisco Fernandez; Elyse Singer; Andrew Levine; Alireza Minagar; Oluwadayo Oluwadara; Taiwo Kotila; Francesco Chiappelli; John T Sinnott
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.